Endovascular revascularisation of lower-extremity peripheral arterial disease: technical and clinical outcomes in a Vietnamese single-center prospective cohort study.
Tan Duy Nguyen, Mai Thi Tuyet Tran, Hanh Ngoc Huynh, Cuong Thao Lam
{"title":"Endovascular revascularisation of lower-extremity peripheral arterial disease: technical and clinical outcomes in a Vietnamese single-center prospective cohort study.","authors":"Tan Duy Nguyen, Mai Thi Tuyet Tran, Hanh Ngoc Huynh, Cuong Thao Lam","doi":"10.1080/14796678.2026.2689421","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To characterize lesion distribution, procedural strategy, and short-term outcomes after endovascular revascularisation for symptomatic lower-extremity peripheral arterial disease (PAD) in routine Vietnamese practice.</p><p><strong>Materials and methods: </strong>This prospective observational cohort included 336 consecutive patients with symptomatic lower-extremity PAD who underwent endovascular revascularisation at a Vietnamese tertiary center from January 2019 to January 2025. Lesions were classified across aorto-iliac, femoropopliteal, and infrapopliteal segments using a TASC-based framework. Outcomes were assessed post-procedure and at 30 days, 3 months, and 6 months.</p><p><strong>Results: </strong>Two-level disease was the most common anatomical pattern (47.3%), followed by three-level disease (36.0%). Contralateral femoral access was most frequently used (39.6%), and drug-coated balloons were the most common device strategy (63.7%). Technical success was achieved in 82.4% (95% CI 78.0-86.1). Access-site complications occurred in 5.7% (95% CI 3.6-8.7), in-hospital mortality was 2.9% (95% CI 1.6-5.4), and immediate hemodynamic success was 82.4% (95% CI 78.0-86.1). Landmark-based restenosis rates were 17.9%, 12.4%, and 24.7% at 30 days, 3 months, and 6 months, respectively.</p><p><strong>Conclusions: </strong>Endovascular revascularisation was feasible in this real-world Vietnamese PAD cohort, but restenosis remained frequent, supporting structured post-procedural surveillance.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"707-716"},"PeriodicalIF":1.1000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13540240/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2026.2689421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To characterize lesion distribution, procedural strategy, and short-term outcomes after endovascular revascularisation for symptomatic lower-extremity peripheral arterial disease (PAD) in routine Vietnamese practice.
Materials and methods: This prospective observational cohort included 336 consecutive patients with symptomatic lower-extremity PAD who underwent endovascular revascularisation at a Vietnamese tertiary center from January 2019 to January 2025. Lesions were classified across aorto-iliac, femoropopliteal, and infrapopliteal segments using a TASC-based framework. Outcomes were assessed post-procedure and at 30 days, 3 months, and 6 months.
Results: Two-level disease was the most common anatomical pattern (47.3%), followed by three-level disease (36.0%). Contralateral femoral access was most frequently used (39.6%), and drug-coated balloons were the most common device strategy (63.7%). Technical success was achieved in 82.4% (95% CI 78.0-86.1). Access-site complications occurred in 5.7% (95% CI 3.6-8.7), in-hospital mortality was 2.9% (95% CI 1.6-5.4), and immediate hemodynamic success was 82.4% (95% CI 78.0-86.1). Landmark-based restenosis rates were 17.9%, 12.4%, and 24.7% at 30 days, 3 months, and 6 months, respectively.
Conclusions: Endovascular revascularisation was feasible in this real-world Vietnamese PAD cohort, but restenosis remained frequent, supporting structured post-procedural surveillance.
目的:在越南常规实践中描述症状性下肢外周动脉疾病(PAD)的病变分布、手术策略和血管内血管重建术后的短期结果。材料和方法:该前瞻性观察队列包括336例有症状的下肢PAD患者,这些患者于2019年1月至2025年1月在越南三级中心接受了血管内重建术。使用基于tasc的框架将病变分为主动脉-髂段、股腘段和股腘下段。在手术后、30天、3个月和6个月时评估结果。结果:二级病变最常见(47.3%),三级病变次之(36.0%)。对侧股骨入路最常用(39.6%),药物包被球囊是最常用的装置策略(63.7%)。技术成功率为82.4% (95% CI 78.0-86.1)。通路部位并发症发生率为5.7% (95% CI 3.6-8.7),住院死亡率为2.9% (95% CI 1.6-5.4),即时血流动力学成功率为82.4% (95% CI 78.0-86.1)。在30天、3个月和6个月时,地标性再狭窄率分别为17.9%、12.4%和24.7%。结论:在越南PAD队列中,血管内血管重建是可行的,但再狭窄仍然频繁,支持结构化的术后监测。
期刊介绍:
Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.